申请人:Global Alliance for TB Drug Development
公开号:US09163020B2
公开(公告)日:2015-10-20
The invention provides compounds of formula (I) and methods of treating a Mycobacterium infection or tuberculosis, or inhibiting DprE1 with the same.
本发明提供了式(I)的化合物以及用于治疗分枝杆菌感染或结核病,或抑制DprE1的方法。